Illumina has made available the world's first multi-sample
whole-genome genotyping arrays that allow researchers to analyse
two samples simultaneously - useful when studying genetic variation
in disease in greater detail.
Mirus Bio has made available a new RNAi tool that analyses gene
function in vivo that allows scientists to study the biological and
physiological impact of a change in gene expression, which is
useful in the identification of new...
Evotec and CHDI have formed a strategic partnership, which aims to
research and develop treatments for Huntington Disease (HD), a
genetic disorder that causes programmed degeneration of brain cells
and loss of intellectual faculties.
deCODE and Illumina have entered an agreement to develop and
commercialise DNA-based diagnostics, in which deCODE will use
Illumina's SNP genotyping platform to expand its contract
genotyping business.
A new genetic research method has revealed interesting insights
into drug metabolism, which could lead to a better understanding
drug selection and dosing regimens in humans.
Gentra Systems has introduced its new versaGene DNA Cell
Purification Kit, which responds to the growing need for
high-quality DNA for sensitive downstream applications. The kit
uses chemistry and column design to purify DNA with...
According to a recent report, pharmacogenetics is unlikely to
become a reality within the next 15-20 years having been 'hyped' by
the media, who are unaware of the many gaps in current
understanding of how genetics relates...
US firms Large Scale Biology Corp and privately-held Planet
Biotechnology have expanded their biomanufacturing program to
extract and purify the latter's lead product, CaroRx, a plant-made
antibody to control dental caries.
A new gene scanning technology, developed by researchers in the UK,
is set to have a major impact on healthcare in the future with the
potential to lead a very personalised genetic profile relevant to
drug prescribing, leading to...
Affymetrix has signed an agreement to acquire ParAllele Bioscience
- a move intended to broaden its variety of microarray
applications. This acquisition builds on a two-year collaboration
between the two companies.
A new signature genetics tool, which allows doctors to personalise
drug therapy, could well have the potential to personalise a
patient's drug regimen based on his/her genetic makeup to minimise
side effects and maximise drug...
A team of gene researchers has sequenced the entire length of the
X-chromosome, providing a starting point to explore the biological
differences between men and woman and a plethora of genes
implicated in human diseases.
EiRx Therapeutics has entered into an agreement with Merck to carry
out research using its cancer cell assays to use its technology for
identifying drug targets.
Qiagen launches a unique siRNA design service that provides a
guarantee that at least 50 per cent of the siRNAs produced will
result in efficient knockdown to the researcher's specific
requirements.
Pharming of the Netherlands, which is pioneering the use of
transgenic animals for the production of biologics, has raised €7
million in new funding and will use the proceeds to advance its
portfolio of clinical drug candidates.
A technique used to conduct fully automated high throughput
mutation detection in microbial genomes, has shown greater
sensitivity over existing methods. The method analyses genetic
modification in bacteria and other disease causing...
Applied Biosystems has announced the introduction of a new workflow
management and process automation solution software that integrates
data form multiple sources for genomics and proteomics
laboratories.
Celera Diagnostics announced it has entered into a collaboration
with Merck to identify novel targets for drug discovery and
diagnostic markers related to Alzheimer's disease.
Affymetrix has extended the range of custom microarrays it offers
to customers with the launch of the NimbleExpress Array Programme,
which caters for users that require fewer units.
The European Union has awarded funding worth €2.2 million to the
group of academic institutes behind the 3DGENOME research
programme, which is exploring how the genome functions in health
and disease.
Researchers have identified a set of genes that control the
development of hair-like structures on cells - called cilia - that
when defective are involved in a range of diseases. They hope the
finding could lead to new drug targets...
Illumina has announced today its latest system for performing DNA
analysis using the company's proven SNP genotyping technology was
being shipped worldwide to customers,writes Wai Lang Chu.
Biotrove has reported promising data from a study of its Living
Chip microfluidic technology used to generate genotyping data from
human genomic samples. Their high-density array chip promises to
hike the throughout rate for this...
A team of international researchers have screened the entire known
genome of the fruit fly (Drospohila melanogaster) for genes
that could play a role in cancer.
Applied Biosystems has launched a new product, based on the
combination of a new set of reagents with a software package, that
promises to speed up genotyping studies carried out on the firm's
3730 and 3730xl analysers, first...
The first draft sequence of the genome of the chimpanzee has been
completed, providing a tantalising first glimpse of the genetic
differences that separates man from one of its closest cousins in
the animal kingdom.
The first grants have been awarded in the ENCODE program,an
extension of the Human Genome Project which is hoping to develop an
encyclopedia of function for all the sequences in the human genetic
map. A $35m pilot project aimed at...
Galapagos Genomics has published details of its RNAi-based gene
silencing technology, based on adenovirus vectors, that is
effective in a range of cell types.
Affymetrix releases into the public domain what it says is the
first significant SNP database that includes genotype data and
allele frequencies across the entire human genome.
Roche forges an alliance with ParAllele to discover genes that
contribute to type 2 diabetes, aimed at identifying potential new
medicines and diagnostics for the disease.
Italian researchers suggest that patients with atrial fibrillation
may have a genetic predisposition linked to expression of
pro-inflammatory proteins.
Prominent US genomics Robert L. Strausberg, who directs the
National Cancer Institute's (NCI) Cancer Genomics office, has been
named as vice president for research at The Institute for Genomic
Research (TIGR).
Researchers have now completed the sequencing of the human genome,
to an accuracy of 99.999 per cent, nearly three years after the
first 'working' draft was published to great fanfare in June 2000.
The achievement comes...
